CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $704K of Corcept Therapeutics Incorporated
Sold$703,656
$35.18Price
20,000Shares
−94%Stake
What CORT did after the filing
- The stock from Fri, Jan 9 open, $36.95
- −1.3%
- S&P 500, same days
- −0.5%
Measured over 30 trading days, to the Feb 24 close.
Traded Tue, Jan 6. Filed Thu, Jan 8, 8:35 PM ET, after the close. Returns use the Jan 9 open and the Feb 24 close. Not investment advice.